Envafolimab Combined With Recombinant Human Endostatin and First-line Chemotherapy Treat of Advanced Mucosal Melanoma

Condition:   Advanced Mucosal Melanoma Intervention:   Drug: Envafolimab combined with recombinant human endostatin and first-line chemotherapy Sponsor:   Fudan University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials